C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/08 (2006.01) A61K 31/351 (2006.01) A61K 31/357 (2006.01) A61K 31/395 (2006.01) C07D 309/06 (2006.01)
Patent
CA 2493821
A substantially purified compound of the formula: a composition comprising a therapeutically effective amount of at least one compound of the formula, alone or in combination with at least one additional therapeutic agent, and methods of preventing or treating cancer and a condition treatable by the inhibition of vacuolar-type (H+)-ATPase
La présente invention concerne un composé sensiblement purifié représenté par la formule I, une composition comprenant une quantité thérapeutiquement efficace d'au moins un composé représenté par la formule (I), seul ou en combinaison avec au moins un autre agent thérapeutique, ainsi que des méthodes de prévention et de traitement du cancer et d'un état pouvant être traité par l'inhibition de la ATPase vacuolaire de type (H+). Formule (I)
Boyd Michael R.
Gustafson Kirk R.
Department Of Health And Human Services The Government Of The United States Of America Represented By Th
Ridout & Maybee Llp
LandOfFree
Chondropsin-class antitumor v-atpase inhibitor compounds,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chondropsin-class antitumor v-atpase inhibitor compounds,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chondropsin-class antitumor v-atpase inhibitor compounds,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1470563